ANI Pharmaceuticals
ANIP
ANIP
208 hedge funds and large institutions have $1.14B invested in ANI Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 88 increasing their positions, 43 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 201 → 208 (+7)
9% less call options, than puts
Call options by funds: $721K | Put options by funds: $793K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
208
Holding in Top 10
–
Calls
$721K
Puts
$793K
Top Buyers
| 1 | +$38.2M | |
| 2 | +$34.5M | |
| 3 | +$20.8M | |
| 4 |
Millennium Management
New York
|
+$18.3M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16.4M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$8.36M | |
| 3 | -$5.63M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.54M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$4.96M |